These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9628521)

  • 1. Steroidal 'add-back' therapy in patients treated with GnRH agonists.
    Freundl G; Gödtke K; Gnoth C; Godehardt E; Kienle E
    Gynecol Obstet Invest; 1998; 45 Suppl 1():22-30; discussion 35. PubMed ID: 9628521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enatone-Gyn monthly depot): a multicenter study].
    Schindler AE; Bühler K; Gerhard I; Wiedemann R; Kimmig R; Schüssler B; Kranzfelder D; Mall-Häfeli M; Meinen K; Mancarella D
    Zentralbl Gynakol; 1994; 116(12):679-86. PubMed ID: 7846980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose add-back therapy during postoperative GnRH agonist treatment.
    Tsai HW; Wang PH; Huang BS; Twu NF; Yen MS; Chen YJ
    Taiwan J Obstet Gynecol; 2016 Feb; 55(1):55-9. PubMed ID: 26927249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotropin-releasing hormone agonists.
    Gnoth CH; Gödtke K; Freundl G; Godehardt E; Kienle E
    Gynecol Obstet Invest; 1999; 47(1):37-41. PubMed ID: 9852390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group.
    Agarwal SK; Hamrang C; Henzl MR; Judd HL
    J Reprod Med; 1997 Jul; 42(7):413-23. PubMed ID: 9252932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.
    Hornstein MD; Surrey ES; Weisberg GW; Casino LA
    Obstet Gynecol; 1998 Jan; 91(1):16-24. PubMed ID: 9464714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study.
    Gerhard I; Schindler AE; Bühler K; Winkler U; Meinen K; Mancarella D; Hoffmann G; Schüssler B; Kimmig R; Kranzfelder D
    Clin Ther; 1992; 14 Suppl A():3-16. PubMed ID: 1535021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
    Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
    Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial.
    Fernandez H; Lucas C; Hédon B; Meyer JL; Mayenga JM; Roux C
    Hum Reprod; 2004 Jun; 19(6):1465-71. PubMed ID: 15105403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
    Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M
    Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of GnRH-a combine with laparoscope conservative surgery in the treatment of the moderate or severe endometriosis].
    Zhong YJ; Zhang W; Zhang WT; Cheng J; Lü QY; Zeng KK
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):180-2. PubMed ID: 23849939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
    Li Z; Zhang HY; Zhu YJ; Hu YJ; Qu PP
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up.
    Surrey ES; Hornstein MD
    Obstet Gynecol; 2002 May; 99(5 Pt 1):709-19. PubMed ID: 11978277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed oral estradiol combined with leuprolide increases endometriosis-related pain.
    Hurst BS; Gardner SC; Tucker KE; Awoniyi CA; Schlaff WD
    JSLS; 2000; 4(2):97-101. PubMed ID: 10917114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of long-term follow-up in treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enantone-Gyn monthly depot)].
    Regidor PA; Schindler AE; Bühler K; Gerhard I; Kimmig R; Meinen K; Hoffmann G; Lübben G; Kienle E
    Zentralbl Gynakol; 1996; 118(5):283-90. PubMed ID: 8701625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Add-back therapy in the treatment of endometriosis-associated pain.
    Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
    Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome.
    Mitwally MF; Gotlieb L; Casper RF
    Menopause; 2002; 9(4):236-41. PubMed ID: 12082359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
    Surrey ES; Voigt B; Fournet N; Judd HL
    Fertil Steril; 1995 Apr; 63(4):747-55. PubMed ID: 7890057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.